The Food and Drug Administration (FDA) has updated the labeling for Kisunla ™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer ...

The table below is a review of notable updates that occurred in June 2025 for investigational products in development (not an inclusive list). Click on ...

Measles, one of the world’s most contagious diseases, was declared eliminated in the US in 2000, due to widespread use of the measles-mumps-rubella vaccine.

Recommendations focus on radiation therapy and/or adjunctive therapies for WHO grade 4 adult-type diffuse glioma.

Exposure-response association seen between trihalomethanes and CKD risk; highest risk seen for brominated trihalomethanes.

Increased risk seen in adjusted analyses in association with nucleoside and nucleotide reverse transcriptase inhibitor use.

The REMS program for the ERA drug class was established due to the risk of embryofetal toxicity seen from animal studies.